These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27342612)

  • 1. The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy.
    Tetreault L; Kopjar B; Nouri A; Arnold P; Barbagallo G; Bartels R; Qiang Z; Singh A; Zileli M; Vaccaro A; Fehlings MG
    Eur Spine J; 2017 Jan; 26(1):78-84. PubMed ID: 27342612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.
    Lubelski D; Alvin MD; Nesterenko S; Sundar SJ; Thompson NR; Benzel EC; Mroz TE
    J Neurosurg Spine; 2016 Mar; 24(3):483-9. PubMed ID: 26613280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Minimum Clinically Important Difference of the Modified Japanese Orthopaedic Association Scale in Patients with Degenerative Cervical Myelopathy.
    Tetreault L; Nouri A; Kopjar B; Côté P; Fehlings MG
    Spine (Phila Pa 1976); 2015 Nov; 40(21):1653-9. PubMed ID: 26502097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy.
    Tetreault L; Wilson JR; Kotter MR; Nouri A; Côté P; Kopjar B; Arnold PM; Fehlings MG
    Neurosurg Focus; 2016 Jun; 40(6):E14. PubMed ID: 27246484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the modified Japanese Orthopaedic Association scale in patients with cervical spondylotic myelopathy.
    Kopjar B; Tetreault L; Kalsi-Ryan S; Fehlings M
    Spine (Phila Pa 1976); 2015 Jan; 40(1):E23-8. PubMed ID: 25341993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopathy disability index: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy.
    Pons Carreto A; Ramírez Valencia M; de García Frutos A; Khoudeir Avila A; Montesinos Magraner L; Nuñez-Pereira S; Haddad S; Pellisé Urquiza F
    Eur Spine J; 2023 Feb; 32(2):584-589. PubMed ID: 36596911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Preoperative Duration of Symptoms a Significant Predictor of Functional Outcomes in Patients Undergoing Surgery for the Treatment of Degenerative Cervical Myelopathy?
    Tetreault L; Wilson JR; Kotter MRN; Côté P; Nouri A; Kopjar B; Arnold PM; Fehlings MG
    Neurosurgery; 2019 Nov; 85(5):642-647. PubMed ID: 30445506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Surgery for Mild Degenerative Cervical Myelopathy: Results of the AOSpine North America and International Prospective Multicenter Studies.
    Badhiwala JH; Witiw CD; Nassiri F; Akbar MA; Mansouri A; Wilson JR; Fehlings MG
    Neurosurgery; 2019 Apr; 84(4):890-897. PubMed ID: 29684181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dynamic alignment, motion, and center of rotation on myelopathy grade and regional disability in cervical spondylotic myelopathy.
    Liu S; Lafage R; Smith JS; Protopsaltis TS; Lafage VC; Challier V; Shaffrey CI; Radcliff K; Arnold PM; Chapman JR; Schwab FJ; Massicotte EM; Yoon ST; Fehlings MG; Ames CP
    J Neurosurg Spine; 2015 Dec; 23(6):690-700. PubMed ID: 26315953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between degree of subvoxel spinal cord compression measured with super-resolution tract density imaging and neurological impairment in cervical spondylotic myelopathy.
    Ellingson BM; Salamon N; Woodworth DC; Holly LT
    J Neurosurg Spine; 2015 Jun; 22(6):631-8. PubMed ID: 25746116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Upper Limb Impairment Related to Degenerative Cervical Myelopathy: Development of a Sensitive Hand Assessment (Graded Redefined Assessment of Strength, Sensibility, and Prehension Version Myelopathy).
    Kalsi-Ryan S; Riehm LE; Tetreault L; Martin AR; Teoderascu F; Massicotte E; Curt A; Verrier MC; Velstra IM; Fehlings MG
    Neurosurgery; 2020 Mar; 86(3):E292-E299. PubMed ID: 31792501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies.
    Bohm PE; Fehlings MG; Kopjar B; Tetreault LA; Vaccaro AR; Anderson KK; Arnold PM
    Spine J; 2017 Feb; 17(2):211-217. PubMed ID: 27592193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminectomy and fusion versus laminoplasty for the treatment of degenerative cervical myelopathy: results from the AOSpine North America and International prospective multicenter studies.
    Fehlings MG; Santaguida C; Tetreault L; Arnold P; Barbagallo G; Defino H; Kale S; Zhou Q; Yoon TS; Kopjar B
    Spine J; 2017 Jan; 17(1):102-108. PubMed ID: 27597512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.
    Tetreault LA; Kopjar B; Vaccaro A; Yoon ST; Arnold PM; Massicotte EM; Fehlings MG
    J Bone Joint Surg Am; 2013 Sep; 95(18):1659-66. PubMed ID: 24048553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning algorithms for prediction of health-related quality-of-life after surgery for mild degenerative cervical myelopathy.
    Khan O; Badhiwala JH; Witiw CD; Wilson JR; Fehlings MG
    Spine J; 2021 Oct; 21(10):1659-1669. PubMed ID: 32045708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.
    Kalsi-Ryan S; Singh A; Massicotte EM; Arnold PM; Brodke DS; Norvell DC; Hermsmeyer JT; Fehlings MG
    Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S111-22. PubMed ID: 23963009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the patient-derived modified Japanese Orthopaedic Association scale and the European myelopathy score.
    de Dios E; Löfgren H; Laesser M; Lindhagen L; Björkman-Burtscher IM; MacDowall A
    Eur Spine J; 2024 Mar; 33(3):1205-1212. PubMed ID: 38112768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study.
    Kato S; Oshima Y; Oka H; Chikuda H; Takeshita Y; Miyoshi K; Kawamura N; Masuda K; Kunogi J; Okazaki R; Azuma S; Hara N; Tanaka S; Takeshita K
    PLoS One; 2015; 10(4):e0123022. PubMed ID: 25837285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Outcomes of Surgical Treatment for Ossification of the Posterior Longitudinal Ligament Versus Other Forms of Degenerative Cervical Myelopathy: Results from the Prospective, Multicenter AOSpine CSM-International Study of 479 Patients.
    Nakashima H; Tetreault L; Nagoshi N; Nouri A; Arnold P; Yukawa Y; Toyone T; Tanaka M; Zhou Q; Fehlings MG
    J Bone Joint Surg Am; 2016 Mar; 98(5):370-8. PubMed ID: 26935459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy: Analysis of an International Prospective Multicenter Data Set of 757 Subjects.
    Tetreault L; Kopjar B; Côté P; Arnold P; Fehlings MG
    J Bone Joint Surg Am; 2015 Dec; 97(24):2038-46. PubMed ID: 26677238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.